These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30257868)

  • 1. Mechanism of action of the viral chemokine-binding protein E163 from ectromelia virus.
    Heidarieh H; Alcamí A
    J Biol Chem; 2018 Nov; 293(45):17418-17429. PubMed ID: 30257868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain.
    Ruiz-Argüello MB; Smith VP; Campanella GS; Baleux F; Arenzana-Seisdedos F; Luster AD; Alcami A
    J Virol; 2008 Jan; 82(2):917-26. PubMed ID: 18003726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.
    Pontejo SM; Murphy PM
    J Biol Chem; 2017 Jun; 292(23):9613-9626. PubMed ID: 28432120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine cooperativity is caused by competitive glycosaminoglycan binding.
    Verkaar F; van Offenbeek J; van der Lee MMC; van Lith LHCJ; Watts AO; Rops ALWMM; Aguilar DC; Ziarek JJ; van der Vlag J; Handel TM; Volkman BF; Proudfoot AEI; Vischer HF; Zaman GJR; Smit MJ
    J Immunol; 2014 Apr; 192(8):3908-3914. PubMed ID: 24639348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.
    Dyer DP; Salanga CL; Volkman BF; Kawamura T; Handel TM
    Glycobiology; 2016 Mar; 26(3):312-26. PubMed ID: 26582609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans.
    Webb LM; Smith VP; Alcami A
    FASEB J; 2004 Mar; 18(3):571-3. PubMed ID: 14734646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants of chemokine binding by an Ectromelia virus-encoded decoy receptor.
    Arnold PL; Fremont DH
    J Virol; 2006 Aug; 80(15):7439-49. PubMed ID: 16840324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
    Crijns H; Vanheule V; Proost P
    Front Immunol; 2020; 11():483. PubMed ID: 32296423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycan binding properties of the myxoma virus CC-chemokine inhibitor, M-T1.
    Seet BT; Barrett J; Robichaud J; Shilton B; Singh R; McFadden G
    J Biol Chem; 2001 Aug; 276(32):30504-13. PubMed ID: 11369757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.
    Zhao B; Liwang PJ
    Biochemistry; 2010 Aug; 49(33):7012-22. PubMed ID: 20712376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of protein function by glycosaminoglycans--as exemplified by chemokines.
    Handel TM; Johnson Z; Crown SE; Lau EK; Proudfoot AE
    Annu Rev Biochem; 2005; 74():385-410. PubMed ID: 15952892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus.
    Vanheule V; Vervaeke P; Mortier A; Noppen S; Gouwy M; Snoeck R; Andrei G; Van Damme J; Liekens S; Proost P
    Biochem Pharmacol; 2016 Jan; 100():73-85. PubMed ID: 26551597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs.
    Tanino Y; Coombe DR; Gill SE; Kett WC; Kajikawa O; Proudfoot AE; Wells TN; Parks WC; Wight TN; Martin TR; Frevert CW
    J Immunol; 2010 Mar; 184(5):2677-85. PubMed ID: 20124102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses.
    Montanuy I; Alejo A; Alcami A
    FASEB J; 2011 Jun; 25(6):1960-71. PubMed ID: 21372110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
    Proudfoot AE; Handel TM; Johnson Z; Lau EK; LiWang P; Clark-Lewis I; Borlat F; Wells TN; Kosco-Vilbois MH
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1885-90. PubMed ID: 12571364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chapter 4. Interactions of chemokines with glycosaminoglycans.
    Hamel DJ; Sielaff I; Proudfoot AE; Handel TM
    Methods Enzymol; 2009; 461():71-102. PubMed ID: 19480915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of host response modifier ORFs of ectromelia virus, the causative agent of mousepox.
    Chen N; Buller RM; Wall EM; Upton C
    Virus Res; 2000 Feb; 66(2):155-73. PubMed ID: 10725549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions.
    Dyer DP; Salanga CL; Johns SC; Valdambrini E; Fuster MM; Milner CM; Day AJ; Handel TM
    J Biol Chem; 2016 Jun; 291(24):12627-12640. PubMed ID: 27044744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of chemokine-glycosaminoglycan interaction specificity.
    Kawashima H
    Methods Enzymol; 2006; 416():254-63. PubMed ID: 17113871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.